"BTA is currently overpriced and it's not surprising that the price dropped after an underwhelming profit announcement. $1.60 to $1.0 is about where the stock should be at, at the moment."
Um, thems fightin words lol. Statements without backup. Course its gunna annoy people. Why exactly is the $38M profit underwhelming?
I think its a good profit considering (1) its a biotech & (2) its only capitalised at $350M (3) the stockmarket is littered with GFC impacted companies fighting for their lives
Um, a 0.11c cap return on your valuation of $1-1.60 yields 11-7%. I'll take that any day o the week.
Add to My Watchlist
What is My Watchlist?